Imagion Biosystems Limited IBXXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 400.20K | 221.70K | 47.30K | 367.40K | 697.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 400.20K | 221.70K | 47.30K | 367.40K | 697.00K |
| Cost of Revenue | 2.09M | 1.72M | 1.36M | 897.70K | 432.70K |
| Gross Profit | -1.69M | -1.50M | -1.32M | -530.40K | 264.20K |
| SG&A Expenses | 1.07M | 1.01M | 953.70K | 908.10K | 870.70K |
| Depreciation & Amortization | 4.20K | 4.90K | 5.60K | 6.70K | 7.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.17M | 2.74M | 2.32M | 1.81M | 1.31M |
| Operating Income | -2.77M | -2.52M | -2.28M | -1.45M | -614.50K |
| Income Before Tax | -3.13M | -2.96M | -2.79M | -2.10M | -1.41M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.13 | -2.96 | -2.79 | -2.10 | -1.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.13M | -2.96M | -2.79M | -2.10M | -1.41M |
| EBIT | -2.77M | -2.52M | -2.28M | -1.45M | -614.50K |
| EBITDA | -2.77M | -2.52M | -2.27M | -1.43M | -555.50K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.69B | 1.40B | 1.11B | 813.53M | 517.18M |
| Average Diluted Shares Outstanding | 1.69B | 1.40B | 1.11B | 813.53M | 517.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |